MedTrace Logo

Benzodiazepines Deprescribing in the Community Setting: Intervention Feasibility

NCT05929417 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-07-03

No results posted yet for this study

Summary

The goal of this feasibility study is to evaluate the feasibility of an intervention, led by the pharmacist, aiming at benzodiazepines and z-drugs deprescribing in older adults living in the Belgian community setting. The main questions it aims to answer are:

* To what extent will Belgian community pharmacists adhere to the intervention?
* To what extent will patients and general practitioners take up the intervention to deprescribe benzodiazepines and z-drugs?
* To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants?

Participants will receive an educational brochure from their pharmacist. Their pharmacist will also propose to send a new standardized form to their general practitioner to enhance collaboration about a potential benzodiazepine deprescribing.

Researchers will compare this intervention to usual care to see if the intervention is feasible and to gather first data on intervention effectiveness in benzodiazepine deprescribing.

Conditions

  • Benzodiazepine Deprescribing

Interventions

OTHER

END-IT intervention for the community setting

The intervention was described in the arm/group descriptions.

Sponsors & Collaborators

  • EBPracticenet

    collaborator UNKNOWN

  • Fonds National de la Recherche scientifique (FNRS)

    collaborator UNKNOWN

  • Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Anne Spinewine, PhD · UCLouvain, Louvain Drug Research Institute/Clinical pharmacy research group

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-23
Primary Completion
2024-01-31
Completion
2024-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05929417 on ClinicalTrials.gov